WRBY

Warby Parker Inc.

Warby Parker Inc. provides eyewear products. It offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, and contact lenses, as well as accessories, including cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray. The company also offers eye exams and vision tests directly to consumers through its retail stores, website, and mobile apps. As of May 16, 2022, it had 160 retail stores in the United States and Canada. The company was formerly known as JAND, Inc. and changed its name to Warby Parker Inc. in June 2021. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

Warby Parker Inc. (WRBY) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B-); its weakest is Value (D-). The rating has held at C for 267 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
D-
Factor Score 1.1 / 5.0
Growth
C+
Factor Score 2.5 / 5.0
Profitability
C+
Factor Score 2.8 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 457.3
EV / EBITDA 71.7
Rev Growth YoY 10.4%
Gross Margin 53.5%
Price Return 3M 7.2%
Price Return 12M 56.9%
Catalyst Signal 0.00
Market Cap $3.4B
TTM Revenue $934.7M
Price / Sales 3.6
ROE 1.9%

Historical Factor Score Progression

Held C for 267 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-15 D- (1.1) C+ (2.5) C+ (2.8) B- (3.0) C+ (2.6) C (2.4)
2026-11-08 D- (1.0) C+ (2.6) C+ (2.8) C+ (2.8) C+ (2.6) C (2.4)
2026-11-01 D- (1.1) C+ (2.7) C+ (2.8) B- (3.1) C+ (2.7) C (2.5)
2026-10-25 D- (1.1) C+ (2.7) C+ (2.8) B- (3.1) C+ (2.6) C (2.4)
2026-10-18 D- (1.1) C+ (2.7) C+ (2.8) C+ (2.6) C+ (2.6) C (2.4)
Page 1 of 7